 Without any meaningful revenue, Momenta Pharmaceuticals NASDAQ: MNTA second-quarter report was rather uneventful, so its a little surprising to see shares down 13.5 today without any significant news.But perhaps the lack of news is whats making short-term investors head for the exits. 